NewSpring Capital Invests in ContinuumRX

We represented NewSpring Capital, a family of private equity funds providing growth and expansion capital, in its investment in ContinuumRX. ContinuumRx secured $13.5 million in financing and converted notes led by NewSpring Capital and joined by Health Enterprise Partners and others.

ContinuumRx provides home infusion therapies and services to hundreds of patients each month and supports them in their care and recovery through all phases of the healthcare continuum.

You Also May Be Interested In:

  • We served as Tennessee regulatory counsel for Caregiver, Inc., a provider of community-based services and support to more than three thousand individuals with intellectual and developmental disabilities across Texas, Tennessee, Indiana, and Ohio, in its recapitalization by WindRose Health Investors, LLC

    We served as Tennessee regulatory counsel for Caregiver, Inc., a provider of community-based services and support to more than three...
    Client Type: Private Company
  • Representation of Evolent Health, Inc. (NYSE: EVH), a health care company that delivers proven clinical and administrative solutions to payers and providers, in its definitive agreement to sell certain assets of Passport Health Plan, including Passport’s brand, operational and clinical infrastructure, and certain provider and vendor agreements, to Molina Healthcare, Inc.

    We represented Evolent Health, Inc. (NYSE: EVH), a health care company that delivers proven clinical and administrative solutions to payers...
    Client Type: Public Company
  • Representation of Forcura, LLC, a healthcare technology that facilitates continuity of care, in its sale to Accel-KKR, a Silicon Valley-based technology-focused private equity firm

    We represented Forcura, LLC, a healthcare technology that facilitates continuity of care, in its sale to Accel-KKR, a Silicon Valley-based...
    Client Type: Private Company